A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Clinical trial NCT02578914 · COMPLETED

Trial details

NCT number: NCT02578914
Sponsor: Aldeyra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Conjunctivitis Seasonal Allergies

Start date: 2015-08-01
Primary completion: 2015-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.